skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 22,292  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Aged, 80 And Over remove subject: Oncology remove subject: Retrospective Studies remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Material Type:
Article
Add to My Research

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Cancer, 2020-06, Vol.126 (11), p.2637-2647 [Peer Reviewed Journal]

2020 American Cancer Society ;2020 American Cancer Society. ;ISSN: 0008-543X ;EISSN: 1097-0142 ;DOI: 10.1002/cncr.32795 ;PMID: 32129883

Digital Resources/Online E-Resources

2
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer
Material Type:
Article
Add to My Research

Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

Journal of thoracic oncology, 2020-05, Vol.15 (5), p.700-704 [Peer Reviewed Journal]

2020 International Association for the Study of Lung Cancer ;Copyright © 2020 by the International Association for the Study of Lung Cancer ;Copyright © 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. ;2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. 2020 International Association for the Study of Lung Cancer ;ISSN: 1556-0864 ;EISSN: 1556-1380 ;DOI: 10.1016/j.jtho.2020.02.010 ;PMID: 32114094

Full text available

3
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
Material Type:
Article
Add to My Research

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial

The lancet oncology, 2020-04, Vol.21 (4), p.508-518 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30074-7 ;PMID: 32135080

Full text available

4
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
Material Type:
Article
Add to My Research

Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study

Journal of clinical oncology, 2022-03, Vol.40 (7), p.752-761 [Peer Reviewed Journal]

2022 by American Society of Clinical Oncology 2022 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.01874 ;PMID: 34990208

Full text available

5
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
Material Type:
Article
Add to My Research

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of clinical oncology, 2020-09, Vol.38 (27), p.3119-3128 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.02104 ;PMID: 32401634

Full text available

6
Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade
Material Type:
Article
Add to My Research

Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade

Journal of clinical oncology, 2020-05, Vol.38 (15), p.1655-1663 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.01464 ;PMID: 32053428

Full text available

7
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
Material Type:
Article
Add to My Research

Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study

The Lancet Oncology, 2020-07, Vol.21 (7), p.904-913 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30310-7 ;PMID: 32479787

Digital Resources/Online E-Resources

8
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series
Material Type:
Article
Add to My Research

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

Annals of oncology, 2018-05, Vol.29 (5), p.1180-1188 [Peer Reviewed Journal]

2018 THE AUTHORS ;The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdy058 ;PMID: 29432521

Full text available

9
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
Material Type:
Article
Add to My Research

Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy

JAMA oncology, 2019-04, Vol.5 (4), p.e185896 [Peer Reviewed Journal]

EISSN: 2374-2445 ;DOI: 10.1001/jamaoncol.2018.5896 ;PMID: 30629084

Digital Resources/Online E-Resources

10
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
Material Type:
Article
Add to My Research

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

The lancet oncology, 2018-12, Vol.19 (12), p.1579-1589 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 2018 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(18)30608-9 ;PMID: 30442497

Full text available

11
Analysis of Margin Classification Systems for Assessing the Risk of Local Recurrence After Soft Tissue Sarcoma Resection
Material Type:
Article
Add to My Research

Analysis of Margin Classification Systems for Assessing the Risk of Local Recurrence After Soft Tissue Sarcoma Resection

Journal of clinical oncology, 2018-03, Vol.36 (7), p.704-709 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.74.6941 ;PMID: 29346043

Full text available

12
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis
Material Type:
Article
Add to My Research

Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis

Journal of clinical oncology, 2016-01, Vol.34 (3), p.219-226 [Peer Reviewed Journal]

2015 by American Society of Clinical Oncology. ;2015 by American Society of Clinical Oncology 2015 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.61.3778 ;PMID: 26503201

Full text available

13
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
Material Type:
Article
Add to My Research

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

Annals of oncology, 2019-07, Vol.30 (7), p.1096-1103 [Peer Reviewed Journal]

2019 THE AUTHORS ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz134 ;PMID: 31038663

Full text available

14
COVID-19 in patients with lung cancer
Material Type:
Article
Add to My Research

COVID-19 in patients with lung cancer

Annals of oncology, 2020-10, Vol.31 (10), p.1386-1396 [Peer Reviewed Journal]

2020 European Society for Medical Oncology ;Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. ;2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. 2020 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.06.007 ;PMID: 32561401

Full text available

15
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
Material Type:
Article
Add to My Research

Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma

Journal of clinical oncology, 2016-02, Vol.34 (5), p.452-459 [Peer Reviewed Journal]

2015 by American Society of Clinical Oncology. ;2015 by American Society of Clinical Oncology 2015 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2015.61.4925 ;PMID: 26628466

Full text available

16
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
Material Type:
Article
Add to My Research

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

Annals of oncology, 2019-08, Vol.30 (8), p.1321-1328 [Peer Reviewed Journal]

2019 THE AUTHORS ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2019 ;The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. ;Distributed under a Creative Commons Attribution 4.0 International License ;2019 THE AUTHORS 2019 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdz167 ;PMID: 31125062

Full text available

17
Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
Material Type:
Article
Add to My Research

Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study

Hepatology (Baltimore, Md.), 2021-11, Vol.74 (5), p.2342 [Peer Reviewed Journal]

2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. ;EISSN: 1527-3350 ;DOI: 10.1002/hep.31819 ;PMID: 33739462

Digital Resources/Online E-Resources

18
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
Material Type:
Article
Add to My Research

Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic

Journal of clinical oncology, 2017-07, Vol.35 (20), p.2299-2305 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.69.2327 ;PMID: 28410011

Full text available

19
Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study
Material Type:
Article
Add to My Research

Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study

Journal of clinical oncology, 2020-04, Vol.38 (10), p.1030-1040 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.03012 ;PMID: 32031867

Full text available

20
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
Material Type:
Article
Add to My Research

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199

Journal of clinical oncology, 2014-09, Vol.32 (27), p.2959-2966 [Peer Reviewed Journal]

2014 by American Society of Clinical Oncology 2014 ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2013.55.0491 ;PMID: 25071121

Full text available

Results 1 - 20 of 22,292  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1993  (368)
  2. 1993 To 2000  (1,407)
  3. 2001 To 2008  (3,279)
  4. 2009 To 2017  (11,915)
  5. After 2017  (5,324)
  6. More options open sub menu

Resource Type 

  1. Articles  (22,288)
  2. Book Chapters  (3)
  3. magazinearticle  (1)
  4. More options open sub menu

Subject 

  1. Aged  (22,139)
  2. Science & Technology  (21,919)
  3. Life Sciences & Biomedicine  (21,739)
  4. Middle Aged  (21,106)
  5. Female  (20,633)
  6. Adult  (18,163)
  7. Male  (17,129)
  8. Prognosis  (8,436)
  9. Treatment Outcome  (5,823)
  10. Neoplasm Staging  (5,738)
  11. Follow-Up Studies  (5,123)
  12. Survival Rate  (4,982)
  13. Young Adult  (4,964)
  14. Medicine  (4,577)
  15. Surgery  (4,571)
  16. Biological And Medical Sciences  (4,412)
  17. More options open sub menu

Language 

  1. English  (22,203)
  2. Japanese  (3,844)
  3. French  (88)
  4. Portuguese  (74)
  5. Spanish  (40)
  6. Chinese  (11)
  7. German  (10)
  8. Norwegian  (4)
  9. Russian  (2)
  10. Turkish  (1)
  11. More options open sub menu

Searching Remote Databases, Please Wait